Anda di halaman 1dari 32

Neuropati Diabetes

Diabetes & Neuropati

Makroangipati Ulkus pedis (luka di kaki)


Diabetes
Melitus Fraktur/trauma/jatuh
Mikroangiopati
Amputasi
Kecacatan
Neuropati
Biaya perawatan >>>
Diabetes
Mortalitas >>>
Kualitas hidup <<<
Focal/
Diffuse
Multifocal

Polineuropati DM Mononeuropati
Autonom Radikulopati/Poliradikulopati
(ADA, 2017; Jia, 2014; Busui, 2017;
Vinik, 2008, Saha, 2014)
Kriteria Diabetes Melitus

Kadar HbA1C ≥6,5% 5,7 – 6,4%

Prediabetes
Kadar Glukosa Darah Puasa (GDP) ≥ 126 mg/dL 100 -125 mg/dL

Kadar Glukosa Darah 2 jam setelah makan ≥ 200 mg/dL 140 – 199 mg/dL

Gejala klasik hiperglikemia atau krisis hiperglikemia, disertai kadar glukosa darah acak ≥ 200
mg/dL

Neuropati
Diabetes
Adanya tanda dan/atau gejala disfungsi saraf perifer pada pasien
dengan diabetes setelah penyebab lain dieksklusi
Neuropati Diabetes

Neuropati Diabetes
• salah satu komplikasi Diabetes Melitus (DM) yg paling sering terjadi & cukup serius

Polineuropati DM Distal symmetric polyneuropathy (DSPN)


• bentuk yang paling banyak ditemukan pada neuropati diabetes (sekitar 75%)
• berkontribusi terhadap kejadian fraktur dan trauma (jatuh) akibat disfungsi serabut saraf ->ketidakstabilan posisi
pasien, trauma minor berulang, dan peningkatan resiko jatuh

Ulkus pedis dan CN Komplikasi Lanjut


• meningkatkan resiko amputasi dan biaya perawatan pada polineuropati DM dan juga sekaligus angka mortalitasnya
Neuropati Diabetes

Neuropati diabetes dapat asimtomatis (Up to 50% (ADA 2017)), tidak adanya
gejala bukan berarti tidak ada neuropati.

Diabetes neuropati sulit diterapi

Identifikasi & kontrol faktor resiko  mencegah neuropati

Deteksi dini penting  mencegah progesifitas

Deteksi dan tata laksana yang baik dapat memperbaiki keluhan/gejala,


meminimalkan sekuel, & meningkatkan kualitas hidup
Neuropati Diabetes

• Prosentase neuropati pada penderita DM berkisar 50-75%


• CDC (Center of Disease Control)  60-70%
• Sebagian besar dg gejala nyeri
Tipe Neuropati Diabetes

Neuropati DM

Polineuropati
Poli-/
DM/ DSPN Autonom Mononeuropati
Radikulopati
(75%)

Subklinis
Faktor Resiko

HbA1C/kadar
Usia Durasi Tinggi Badan
gula darah

Hipertensi Profil lemak Berat Badan

Sindroma
metabolik

Alkohol Merokok
• Anamnesa
 Keluhan sensoris, tipe nyeri, durasi, lokasi nyeri
 Penyakit penyerta
 Faktor resiko

• Pemeriksaan fisik

• Pemeriksaan tambahan
Keluhan

• Tebal, kesemutan, kesetrum,


gangguan keseimbangan

• Nyeri: terbakar,
ditusuk-tusuk, seperti disilet

• Hiperalgesia
Pemeriksaan
Subyektif
• Pin prick
• Garpu tala
• Monofilamen
• Diskriminasi panas dan
dingin

Obyektif
• Reflek ankle/pergelangan kaki
• Tes Kuantitas Sensoris (QST)
• Biopsi kulit dan densitas intraepidermal nerve fiber (IENF)
• Corneal confocal microscopy
• Contact heat evoked potential
• Fungsi sudomotor
• Pemeriksaan konduksi saraf (ENMG)
Penyakit
Lain ??

(American Diabetes Association, 2017)


Pengobatan

Farmakologi Non Farmakologi


Background, cont.
• Pharmacologic Agents:
 Anticonvulsants, antidepressants, opioids, antiarrhythmics, cannabinoids,
aldose reductase inhibitors, protein kinase C beta inhibitors, antioxidants (α-
lipoic acid), transketolase activators (thiamines and allithiamines), topical
medications (analgesic patches, anesthetic patches, capsaicin cream,
clonidine), and others
• Nonpharmacologic Modalities:
 Infrared therapy, shoe magnets, exercise, acupuncture, external stimulation
(transcutaneous electrical nerve stimulation), spinal cord stimulation,
biofeedback and behavioral therapy, surgical decompression, and intrathecal
baclofen

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendation

Conclusions:
• Based on consistent Class I evidence, pregabalin is established as effective in lessening the pain of
PDN .
• Pregabalin also improves QOL and lessens sleep interference, though the effect size is small.

Recommendation:
• If clinically appropriate, pregabalin should be offered for the treatment of PDN (Level A).

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendation

Conclusions:
• Based on 1 Class I study, gabapentin is probably effective in lessening the pain of PDN.
• Based on 2 Class II studies, sodium valproate is probably effective in treating PDN.

Recommendation:
• Gabapentin and sodium valproate should be considered for the treatment of PDN (Level B).

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendations

Conclusions:
• Based on 3 Class I and 5 Class II studies, the antidepressants amitriptyline, venlafaxine, and
duloxetine are probably effective in lessening the pain of PDN .
• Venlafaxine and duloxetine also improve QOL.
• Venlafaxine is superior to placebo in relieving pain when added to gabapentin.

Recommendations:
• Amitriptyline, venlafaxine, and duloxetine should be considered for the treatment of PDN (Level B).
Data are insufficient to recommend one of these agents over the others.
• Venlafaxine may be added to gabapentin for a better response (Level C).

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendation

Conclusions:
• Based on one Class I study, dextromethorphan is probably effective in lessening the pain of PDN and
improving QOL.
• Based on Class II evidence, morphine sulphate, tramadol, and oxycodone controlled-release are
probably effective in lessening the pain of PDN.
• Dextromethorphan, tramadol, and oxycodone controlled-release have moderate effect sizes, reducing
pain by 27% compared with placebo.

Recommendation:
• Dextromethorphan, morphine sulphate, tramadol, and oxycodone should be considered for the
treatment of PDN (Level B). Data are insufficient to recommend one agent over the other.

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendation

Conclusions:
• Based on Class I and Class II evidence, capsaicin cream is probably effective in lessening the pain of
PDN.
• Based on Class I evidence, isosorbide dinitrate spray is probably effective for the treatment of PDN.

Recommendation:
• Capsaicin and isosorbide dinitrate spray should be considered for the treatment of PDN (Level B).

© 2011 AMERICAN ACADEMY OF NEUROLOGY


Conclusions/Recommendations

Conclusions:
• Based on a Class I study, electrical stimulation is probably effective in lessening the pain of PDN and
improving QOL.
• Based on single Class I studies, electromagnetic field treatment, low-intensity laser treatment, and
Reiki therapy are probably not effective for the treatment of PDN.

Recommendations:
• Percutaneous electrical nerve stimulation should be considered for the treatment of PDN (Level B).
• Electromagnetic field treatment, low-intensity laser treatment, and Reiki therapy should probably not be

considered for the treatment of PDN (Level B).

© 2011 AMERICAN ACADEMY OF NEUROLOGY


(American Academy of Neurology, 2011)
Phsycological
support

• Anxietas
• Depresi
• Weight bearing Vs
Non weight bearing
• Foot Exercise
Pencegahan
Kontrol •Cek kadar gula rutin
Gula •Cek kadar HbA1C Sindrom
Darah • berat badan
a • tekanan darah
metaboli • profil lemak
k

• Keluhan Neuropati
Deteksi • Cek kondisi kaki setiap hari
Dini (luka, goresan, pecah2,
kering), potong kuku • Weight bearing vs
Exercise Non weight bearing
(American Diabetes Association, 2017)
(American Diabetes Association, 2017)
to cure sometimes, to heal often,
to comfort always
Exercise diabetic
foot

Anda mungkin juga menyukai